OTCMKTS:CHEOYCOCHLEAR LTD/ADR Stock Price, Forecast & News

$68.00

+0.15 (+0.22 %)

(As of 06/5/2020 04:00 PM ET)

Add

Compare

Today's Range

$68.00

Now: $68.00▼

$68.00

50-Day Range

$56.80

MA: $61.19▼

$68.39

52-Week Range

$43.94

Now: $68.00▼

$84.40

Volume1,270 shs

Average Volume1,824 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. It also provides Cochlear true wireless devices comprising mini microphones, phone clips, and TV streamers; and Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses. The company has strategic collaborations with Sensorion and GN Hearing A/S to focus on improving hearing outcomes in patients with cochlear implants. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for COCHLEAR LTD/ADR.

2.3 Community Rank

Outperform Votes
COCHLEAR LTD/ADR has received 18 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
COCHLEAR LTD/ADR has received 21 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
COCHLEAR LTD/ADR has received 53.85% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about COCHLEAR LTD/ADR and other stocks. Vote “Outperform” if you believe CHEOY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CHEOY will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
COCHLEAR LTD/ADR does not currently pay a dividend.
Dividend Growth
COCHLEAR LTD/ADR does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, COCHLEAR LTD/ADR insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Overall Beat the Market Rank^™

0.46 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Medical Devices

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:CHEOY

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.cochlear.com

Phone61 2 9428 6555

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees3,500

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

Receive CHEOY News and Ratings via Email

Sign-up to receive the latest news and ratings for CHEOY and its competitors with MarketBeat's FREE daily newsletter.

COCHLEAR LTD/ADR (OTCMKTS:CHEOY) Frequently Asked Questions

How has COCHLEAR LTD/ADR's stock been impacted by COVID-19 (Coronavirus)?

COCHLEAR LTD/ADR's stock was trading at $60.24 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CHEOY shares have increased by 12.9% and is now trading at $68.00. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of COCHLEAR LTD/ADR?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for COCHLEAR LTD/ADR in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for COCHLEAR LTD/ADR.

Has COCHLEAR LTD/ADR been receiving favorable news coverage?

News articles about CHEOY stock have trended positive recently, according to InfoTrie. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. COCHLEAR LTD/ADR earned a news impact score of 2.2 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutCOCHLEAR LTD/ADR.

Who are some of COCHLEAR LTD/ADR's key competitors?

Some companies that are related to COCHLEAR LTD/ADR include Cannabix Technologies (BLO), Cochlear (CHEOF), Delcath Systems (DCTH), Ellex Medical Lasers (ELXMF), GN Store Nord A/S (GGNDF), Ion Beam Applications (IOBCF), Micro-X (MX1), Nemaura Medical (NMRD), Neuronetics (VMD), Neuroone Medical Technologies (NMTC), Ortho Regenerative Technologies (ORTH), OTCMKTS:ODYY (ODYY), PetVivo (PETV), Protech Home Medical (PTQQF) and Rafina Innovations (VICA). View all competitors.

Who are COCHLEAR LTD/ADR's key executives?

COCHLEAR LTD/ADR's management team includes the following people:

Mr. Diggory William Howitt, CEO, MD, Pres & Exec. Director (Age 52)
Mr. Brent Andrew Cubis, Chief Financial Officer
Mr. Jan Janssen, Chief Technology Officer
Mr. Richard Brook, Pres of EMEA & Latin American Region
Mr. Anthony Manna, Pres of Americas Region

What is COCHLEAR LTD/ADR's stock symbol?

COCHLEAR LTD/ADR trades on the OTCMKTS under the ticker symbol "CHEOY."

How do I buy shares of COCHLEAR LTD/ADR?

Shares of CHEOY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is COCHLEAR LTD/ADR's stock price today?

One share of CHEOY stock can currently be purchased for approximately $68.00.

What is COCHLEAR LTD/ADR's official website?

The official website for COCHLEAR LTD/ADR is www.cochlear.com.

How can I contact COCHLEAR LTD/ADR?

The company can be reached via phone at 61 2 9428 6555.

This page was last updated on 6/6/2020 by MarketBeat.com Staff